These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 1500820)
41. FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor-alpha, ameliorates endotoxin-induced shock. Yamamoto N; Sakai F; Yamazaki H; Sato N; Nakahara K; Okuhara M Eur J Pharmacol; 1997 May; 327(2-3):169-74. PubMed ID: 9200556 [TBL] [Abstract][Full Text] [Related]
42. Role of interleukin 1 and tumor necrosis factor on energy metabolism in rabbits. Tredget EE; Yu YM; Zhong S; Burini R; Okusawa S; Gelfand JA; Dinarello CA; Young VR; Burke JF Am J Physiol; 1988 Dec; 255(6 Pt 1):E760-8. PubMed ID: 3144180 [TBL] [Abstract][Full Text] [Related]
43. Recombinant human tumor necrosis factor and recombinant murine interleukin-1 alter the binding of Escherichia coli to intestine, mucin glycoprotein, and the HT29-C1 intestinal cell line. Wanke CA; Bistrian B Nutrition; 1997; 13(11-12):959-64. PubMed ID: 9433711 [TBL] [Abstract][Full Text] [Related]
45. Circulating tumor necrosis factor and interleukin-1 after administration of LPS in adult cows. Ohtsuka H; Ohki K; Tanaka T; Tajima M; Yoshino T; Takahashi K J Vet Med Sci; 1997 Oct; 59(10):927-9. PubMed ID: 9362043 [TBL] [Abstract][Full Text] [Related]
46. Synergistic stimulation of nitric oxide hemoglobin production in rats by recombinant interleukin 1 and tumor necrosis factor. Kosaka H; Harada N; Watanabe M; Yoshihara H; Katsuki Y; Shiga T Biochem Biophys Res Commun; 1992 Nov; 189(1):392-7. PubMed ID: 1333193 [TBL] [Abstract][Full Text] [Related]
47. The biology of interleukin 1 and comparison to tumor necrosis factor. Dinarello CA Immunol Lett; 1987 Dec; 16(3-4):227-31. PubMed ID: 3127333 [TBL] [Abstract][Full Text] [Related]
49. Parallel relationship between the increase in serotonin in the liver and the hypoglycaemia induced in mice by interleukin-1 and tumour necrosis factor. Endo Y Immunol Lett; 1991 Jan; 27(1):75-9. PubMed ID: 2019424 [TBL] [Abstract][Full Text] [Related]
50. The OVLT initiates the fall in arterial pressure evoked by high dose lipopolysaccharide: evidence that dichotomous, dose-related mechanisms mediate endotoxic hypotension. Feleder C; Sertac Yilmaz M; Peng J; Göktalay G; Millington WR J Neuroimmunol; 2015 Aug; 285():94-100. PubMed ID: 26198924 [TBL] [Abstract][Full Text] [Related]
51. Comparison of the capacity of rhTNF-alpha and Escherichia coli to induce procoagulant activity by baboon mononuclear cells in vivo and in vitro. Li A; Chang AC; Peer GT; Hinshaw LB; Taylor FB Shock; 1996 Apr; 5(4):274-9. PubMed ID: 8721387 [TBL] [Abstract][Full Text] [Related]
52. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. Bertini R; Bianchi M; Ghezzi P J Exp Med; 1988 May; 167(5):1708-12. PubMed ID: 3259257 [TBL] [Abstract][Full Text] [Related]
53. Inhibition of endotoxin-induced interleukin 8 release by teicoplanin in human whole blood. Focà A; Matera G; Berlinghieri MC Eur J Clin Microbiol Infect Dis; 1993 Dec; 12(12):940-4. PubMed ID: 8187790 [TBL] [Abstract][Full Text] [Related]
54. Increased lipopolysaccharide-induced tumour necrosis factor levels and death in hypercholesterolaemic rabbits. Brito BE; Romano EL; Grunfeld C Clin Exp Immunol; 1995 Aug; 101(2):357-61. PubMed ID: 7648721 [TBL] [Abstract][Full Text] [Related]
56. Complement independent lipopolysaccharide (LPS) induced hypotension and disseminated intravascular coagulation: a correlation of LPS structure with in vivo and in vitro biological activities. Ulevitch RJ; Morrison DC; Cochrane CG; Henson PM Adv Exp Med Biol; 1976; 73 PT-A():339-49. PubMed ID: 793350 [No Abstract] [Full Text] [Related]
57. ESR spectral transition by arteriovenous cycle in nitric oxide hemoglobin of cytokine-treated rats. Kosaka H; Sawai Y; Sakaguchi H; Kumura E; Harada N; Watanabe M; Shiga T Am J Physiol; 1994 May; 266(5 Pt 1):C1400-5. PubMed ID: 8203503 [TBL] [Abstract][Full Text] [Related]
58. Role of complement in lethal bacterial lipopolysaccharide-induced hypotensive and coagulative changes. Ulevitch RJ; Cochrane CG Infect Immun; 1978 Jan; 19(1):204-11. PubMed ID: 24001 [TBL] [Abstract][Full Text] [Related]
59. The Sixth John M. Kinney-Nestlé Clinical Nutrition Award for Enteral Nutrition. Recombinant human tumor necrosis factor and recombinant murine interleukin-1 alter the binding of Escherichia coli to intestine, mucin glycoprotein, and the HT29-C1 intestinal cell line: a context. Wanke CA Nutrition; 1999 Jun; 15(6):427-9. PubMed ID: 10378192 [No Abstract] [Full Text] [Related]
60. Potential role of host cytokines in Haemophilus influenzae lipopolysaccharide-induced blood-brain barrier permeability. Scheld WM; Quagliarello VJ; Wispelwey B Pediatr Infect Dis J; 1989 Dec; 8(12):910-11. PubMed ID: 2626302 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]